Phase II trial of epirubicin at standard dose in relapsed ovarian cancer

Eur J Cancer. 1996 May;32A(5):899-900. doi: 10.1016/0959-8049(96)00003-2.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibiotics, Antineoplastic / therapeutic use*
  • Epirubicin / therapeutic use*
  • Female
  • Humans
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Epirubicin